Product Overview
AmnioFix is a bioactive tissue matrix allograft composed of dehydrated human amnion/chorion membrane (dHACM) that preserves and contains multiple extracellular matrix proteins, growth factors, cytokines, and other specialty proteins.
Key Benefits:
â–ª Acts as a barrier membrane
â–ª Reduces scar tissue formation
â–ª Modulates inflammation
â–ª Enhances healing
Important Attributes:
â–ª Terminally sterilized for enhanced patient safety
â–ª PURION® processed to provide an effective
allograft with excellent handling characteristics
â–ª 5 year shelf life stored at ambient conditions
AmnioFix is intended for homologous use to reduce scar tissue formation, modulate inflammation, enhance surgical wound healing, and act as a barrier membrane.
AmnioFix is processed through the proprietary PURION® Process that protects the delicate scaffold during processing, leaving an intact collagen matrix. The result is a durable, bioactive allograft with natural barrier properties which may be stored at ambient conditions for up to 5 years. AmnioFix is available in sheet, particulate, and wrap configurations and in a variety of sizes to reduce wastage.
AmnioFix is processed from human tissue according to the American Association of Tissue Banks (AATB) standards, and is regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under Section 361 of the Public Health Service Act. (https://mimedx.com/)
